---

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED MARCH 31,
  2010

OR

[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number000-53665

MEDICAL CARE TECHNOLOGIES
INC.(Exact name of registrant as specified in its
charter)

NEVADA(State or other jurisdiction
of incorporation or organization)

Room 815, No. 2 Building Beixiaojie, Dongzhimen NeiBeijing, Peoples Republic of China 10009(Address of principal executive offices, including zip code.)

(8610) 6407 0580(Registrants
telephone number, including area code)

Check whether the issuer (1) filed all reports required to be
filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or
for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the last 90 days.YES [X]    NO [   ]

Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation
S-T (§232.405 of this chapter) during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files)
YES [   ]    NO [   ]

Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of large accelerated filer, accelerated
filer, non-accelerated filer, and smaller reporting company in Rule 12b-2
of the Exchange Act.

|Large accelerated Filer[   ]         | Accelerated
      Filer [   ]
|------------------------------------ | -----------------------------
|Non-accelerated Filer    [ 
       ] | Smaller Reporting Company[X] 

Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act).YES [ 
 ]    NO [X]

State the number of shares outstanding of each of the issuers
classes of common equity, as of the latest practicable date: 99,400,000 as of
May 24, 2010.

---

- 2 -

ITEM 1. FINANCIAL STATEMENTS.



---

Medical Care Technologies Inc. 
  (A Development Stage Company) 
  March 31, 2010



|                                                                 | Index
|---------------------------------------------------------------- | -----
|                                                                 |      
|Consolidated
      Balance Sheets (unaudited)                    | F-1  
|                                                                 |      
|Consolidated
      Statements of Expenses (unaudited)            | F-2  
|                                                                 |      
|Consolidated
      Statements of Cash Flows (unaudited)          | F-3  
|                                                                 |      
|Notes
      to the Consolidated Financial Statements (unaudited) | F-4  

---

Medical Care Technologies Inc. 
  (A Development Stage Company) 
  Consolidated Balance Sheets 
  (unaudited)

|                                                                                  |   | March 31, |   |   | December 31, |  
|--------------------------------------------------------------------------------- | - | --------- | - | - | ------------ | -
|                                                                                  |   | 2010      |   |   | 2009         |  
|                                                                                  |   |           |   |   |              |  
|ASSETS                                                                            |   |           |   |   |              |  
|                                                                                  |   |           |   |   |              |  
|Current Assets                                                                    |   |           |   |   |              |  
|                                                                                  |   |           |   |   |              |  
|Cash and cash equivalents                                                         | $ | 1,185     |   | $ | 475          |  
|Prepaid expenses                                                                  |   | 65,147    |   |   |             |  
|                                                                                  |   |           |   |   |              |  
|Total Current Assets                                                              |   | 66,332    |   |   | 475          |  
|                                                                                  |   |           |   |   |              |  
|Property and equipment, net of accumulated depreciation of
      $10,000          |   | 40,000    |   |   |             |  
|Intangible assets, net of accumulated amortization of
      $105,282              |   | 315,846   |   |   |             |  
|                                                                                  |   |           |   |   |              |  
|Total Assets                                                                      | $ | 422,178   |   | $ | 475          |  
|                                                                                  |   |           |   |   |              |  
|                                                                                  |   |           |   |   |              |  
|LIABILITIES AND STOCKHOLDERS DEFICIT                                             |   |           |   |   |              |  
|                                                                                  |   |           |   |   |              |  
|Current Liabilities                                                               |   |           |   |   |              |  
|Accounts payable                                                                  | $ | 42,614    |   | $ | 31,202       |  
|Due to related parties                                                            |   | 17,485    |   |   | 25,439       |  
|Accrued liabilities                                                               |   | 3,001     |   |   |             |  
|Loans
      payable                                                               |   | 80,987    |   |   | 14,000       |  
|                                                                                  |   |           |   |   |              |  
|Total Current Liabilities                                                         |   | 144,087   |   |   | 70,641       |  
|                                                                                  |   |           |   |   |              |  
|Loans
      payable                                                               |   |          |   |   | 56,740       |  
|                                                                                  |   |           |   |   |              |  
|Total Liabilities                                                                 |   | 144,087   |   |   | 127,381      |  
|                                                                                  |   |           |   |   |              |  
|Stockholders Deficit                                                             |   |           |   |   |              |  
|                                                                                  |   |           |   |   |              |  
|Preferred Stock, 100,000,000 shares authorized, $0.00001
      par value,         |   |           |   |   |              |  
|No shares issued and outstanding as of
      March 31, 2010 and December 31, 2009 |   |          |   |   |             |  
|                                                                                  |   |           |   |   |              |  
|Common Stock, 150,000,000 shares
      authorized, $0.00001 par value,            |   |           |   |   |              |  
|99,400,000 and 98,900,000shares issued and outstanding as
      of                |   |           |   |   |              |  
|March 31, 2010 and December 31, 2009,
      respectively                          |   | 994       |   |   | 989          |  
|                                                                                  |   |           |   |   |              |  
|Additional Paid-in Capital                                                        |   | 621,634   |   |   | 50,511       |  
|                                                                                  |   |           |   |   |              |  
|Deficit Accumulated During the Development Stage                                  |   | (344,537  | ) |   | (178,406     | )
|                                                                                  |   |           |   |   |              |  
|Total Stockholders Deficit                                                       |   | (278,091  | ) |   | (126,906     | )
|                                                                                  |   |           |   |   |              |  
|Total Liabilities and Stockholders Deficit                                       | $ | 422,178   |   | $ | 475          |  

(The accompanying notes are an integral part of these
  consolidated unaudited financial statements) 
  F-1

---

Medical Care Technologies Inc. 
  (A Development Stage Company) 
  Consolidated Statements of Expenses 
  (unaudited)

|                                                                   |   |                            |   |   |              |   |   | Period from       |  
|------------------------------------------------------------------ | - | -------------------------- | - | - | ------------ | - | - | ----------------- | -
|                                                                   |   |                            |   |   |              |   |   | February 27, 2007 |  
|                                                                   |   | For the three months ended |   |   | (Inception)  |  
|                                                                   |   | March 31,                  |   |   | To March 31, |  
|                                                                   |   | 2010                       |   |   | 2009         |   |   | 2010              |  
|                                                                   |   |                            |   |   |              |   |   |                   |  
|Expenses                                                           |   |                            |   |   |              |   |   |                   |  
|General and administrative                                         | $ | 35,612                     |   | $ | 14,815       |   | $ | 110,252           |  
|Depreciation and amortization expense                              |   | 115,282                    |   |   |             |   |   | 115,282           |  
|Management fees                                                    |   | 15,000                     |   |   |             |   |   | 30,692            |  
|Total Expenses                                                     |   | (165,894                   | ) |   | (14,815      | ) |   | (256,226          | )
|Foreign currency exchange
      loss                               |   | (237                       | ) |   | 72           |   |   | (1,001            | )
|Loss Before Discontinued Operations                                |   | (166,131                   | ) |   | (14,743      | ) |   | (257,227          | )
|Loss from Discontinued Operations:                                 |   |                            |   |   |              |   |   |                   |  
|Discontinued operations                                            |   |                           |   |   |             |   |   | (87,310           | )
|Net Loss                                                           | $ | (166,131                   | ) | $ | (14,743      | ) | $ | ( 344,537         | )
|                                                                   |   |                            |   |   |              |   |   |                   |  
|Net Loss Per Common Share  Basic and Diluted:                     |   |                            |   |   |              |   |   |                   |  
|Discontinued Operations                                            |   | N/A                        |   |   | N/A          |   |   |                   |  
|Continued Operations                                               | $ | (0.00                      | ) | $ | (0.00        | ) |   |                   |  
|Net Loss                                                           | $ | (0.00                      | ) | $ | (0.00        | ) |   |                   |  
|                                                                   |   |                            |   |   |              |   |   |                   |  
|Weighted Average Common Shares OutstandingBasic and
      Diluted |   | 99,222,000                 |   |   | 75,261,000   |   |   |                   |  

(The accompanying notes are an integral part of these
  consolidated unaudited financial statements) 
  F-2

---

Medical Care Technologies Inc. 
  (A Development Stage Company) 
  Consolidated Statements of Cash Flows 
  (unaudited)

|                                                                                                   |   |                    |   |   |                     |   |   | Period from       |  
|-------------------------------------------------------------------------------------------------- | - | ------------------ | - | - | ------------------- | - | - | ----------------- | -
|                                                                                                   |   |                    |   |   |                     |   |   | February 27, 2007 |  
|                                                                                                   |   | Three months ended |   |   | (Date of Inception) |  
|                                                                                                   |   | March 31,          |   |   | To March 31,        |  
|                                                                                                   |   | 2010               |   |   | 2009                |   |   | 2010              |  
|                                                                                                   |   |                    |   |   |                     |   |   |                   |  
|                                                                                                   |   |                    |   |   |                     |   |   |                   |  
|Operating Activities                                                                               |   |                    |   |   |                     |   |   |                   |  
|                                                                                                   |   |                    |   |   |                     |   |   |                   |  
|Net loss for the period                                                                            | $ | (166,131           | ) | $ | (14,743             | ) | $ | (344,537          | )
|                                                                                                   |   |                    |   |   |                     |   |   |                   |  
|Adjustment to reconcile net loss
      to cash used in 
               operating
      activities: |   |                    |   |   |                     |   |   |                   |  
|Donated services and expenses                                                                      |   |                   |   |   |                    |   |   | 10,500            |  
|Depreciation and amortization                                                                      |   | 115,282            |   |   |                    |   |   | 115,282           |  
|                                                                                                   |   |                    |   |   |                     |   |   |                   |  
|Changes in operating assets and
      liabilities:                                                 |   |                    |   |   |                     |   |   |                   |  
|Prepaid expenses                                                                                   |   | (65,147            | ) |   |                    |   |   | (65,147           | )
|Accounts payable                                                                                   |   | (12,033            | ) |   | 243                 |   |   | 19,804            |  
|Accrued
      liabilities                                                                          |   | 3,001              |   |   | 2,703               |   |   | 3,001             |  
|Net Cash Used in Operating Activities                                                              |   | (125,028           | ) |   | (11,797             | ) |   | (261,097          | )
|                                                                                                   |   |                    |   |   |                     |   |   |                   |  
|Financing Activities                                                                               |   |                    |   |   |                     |   |   |                   |  
|Bank overdraft                                                                                     |   |                   |   |   | 2,006               |   |   |                  |  
|Issuance of common stock for cash                                                                  |   | 100,000            |   |   |                    |   |   | 141,000           |  
|Due to related party                                                                               |   | 15,491             |   |   |                    |   |   | 40,295            |  
|Loans Payable                                                                                      |   | 10,247             |   |   |                    |   |   | 80,987            |  
|Net Cash
      Provided by Financing Activities                                                    |   | 125,738            |   |   | 2,006               |   |   | 262,282           |  
|                                                                                                   |   |                    |   |   |                     |   |   |                   |  
|Increase (Decrease) in Cash and Cash Equivalent                                                    |   | 710                |   |   | (9,791              | ) |   | 1,185             |  
|                                                                                                   |   |                    |   |   |                     |   |   |                   |  
|Cash
       Beginning of Period                                                                   |   | 475                |   |   | 9,791               |   |   |                  |  
|                                                                                                   |   |                    |   |   |                     |   |   |                   |  
|Cash
       End of Period                                                                         | $ | 1,185              |   | $ |                    |   | $ | 1,185             |  
|                                                                                                   |   |                    |   |   |                     |   |   |                   |  
|Supplemental Disclosures                                                                           |   |                    |   |   |                     |   |   |                   |  
|Interest paid                                                                                      |   |                   |   |   |                    |   |   |                  |  
|Income taxes paid                                                                                  |   |                   |   |   |                    |   |   |                  |  
|                                                                                                   |   |                    |   |   |                     |   |   |                   |  
|Non-Cash Disclosures                                                                               |   |                    |   |   |                     |   |   |                   |  
|                                                                                                   |   |                    |   |   |                     |   |   |                   |  
|Reclass of related party debt to accounts payable                                                  | $ | 23,445             |   | $ |                    |   | $ | 46,255            |  
|Repurchase of common stock                                                                         | $ |                   |   | $ | 15,000              |   | $ |                  |  
|Shares issued for acquisition of assets                                                            | $ | 471,128            |   | $ | -                   |   | $ | 471,128           |  

(The accompanying notes are an integral part of these
  consolidated unaudited financial statements) 
  F-3

---

Medical Care Technologies Inc. 
  (A Development Stage Company) 
  Notes to the Consolidated Financial Statements 
  (unaudited)

|1. | Basis of Presentation and Going Concern                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
|-- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|   | Medical Care Technologies Inc. (the Company) was
      incorporated in the State of Nevada on February 27, 2007 under the name of
      Aventerra Explorations Inc and changed its name from Aventerra
      Exploration Inc to AM Oil Resources & Technology Inc. on December
      3, 2008. On September 28, 2009, the Company incorporated Medical Care
      Technologies Inc. for the sole purpose of effecting a name change. On
      October 6, 2009, the Company effected a merger with the wholly owned
      subsidiary and assumed the subsidiarys name. In conjunction with the name
      change, the Company has also been granted a new trading symbol of MDCE.
      The Company is in the development stage as defined by Financial Accounting
      Standards Board (FASB) Accounting Standards Codification (ASC) 915,
      Development Stage Entities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|   | During the three months ended March 31, 2010, we issued
      57.3 million shares of common stock in connection with the acquisition of
      certain software and computer equipment. The shares represented 57.6% of
      the total issued and outstanding shares of the Company, resulting in a
      change in control. This change of control will limit the utilization of
      our NOL carryforwards in future tax periods.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|   | Going Concern                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|   | These consolidated financial statements have been
      prepared on a going concern basis, which implies the Company will continue
      to realize its assets and discharge its liabilities in the normal course
      of business. The Company has not generated revenues since inception and
      has never paid any dividends and is unlikely to pay dividends or generate
      earnings in the immediate or foreseeable future. The continuation of the
      Company as a going concern is dependent upon the continued financial
      support from its shareholders, the ability of the Company to obtain
      necessary equity financing to continue operations and to determine the
      existence, discovery and successful exploitation of economically
      recoverable reserves in its resource properties, confirmation of the
      Companys interests in the underlying properties, and the attainment of
      profitable operations. As at March 31, 2010, the Company has a working
      capital deficit of $77,755 and has accumulated losses of $344,537 since
      inception. These consolidated financial statements do not include any
      adjustments to the recoverability and classification of recorded asset
      amounts and classification of liabilities that might be necessary should
      the Company be unable to continue as a going concern. These factors raise
      substantial doubt regarding the Companys ability to continue as a going
      concern.
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|   | Consolidation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|   | These consolidated financial statements and related notes
      are presented in accordance with accounting principles generally accepted
      in the United States, and are expressed in US dollars. These consolidated
      financial statements include the accounts of the Company and its wholly
      owned subsidiary, Aventerra Explorations Ltd, a company incorporated in
      England. All inter-company accounts and transactions have been
      eliminated.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|   | Reclassifications                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|   | Certain prior year amounts have been reclassified to
      conform with the current year presentation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|   | Recently Adopted Accounting
      Pronouncements                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|   | The Company has implemented all new accounting
      pronouncements that are in effect and that may impact its financial
      statements and does not believe that there are any other new accounting
      pronouncements that have been issued that might have a material impact on
      its financial position or results of operations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|2. | Asset Acquisition Agreement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|   | On January 9, 2010, the Company entered into an Asset
      Acquisition Agreement to acquire various computers, software, and
      technologies (the assets) held by Great Union Corporation (Great
      Union), a Hong Kong corporation. In consideration, the Company agreed to
      issue 57,300,000 shares of its common stock, which represents a
      controlling interest in Medical Care Technologies, Inc. As a result of
      this transaction, there was a change of control.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|   | Based on the change in ownership, the assets were
      recorded based on historical basis and totaled $471,128. Pursuant to the
      agreement, on February 1, 2010, the Company cancelled 57,300,000 shares of
      common stock from the former President of the Company and issued these
      shares to Great Union .                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|   | The assets acquired are stated at cost and has the
      following remaining useful lives. Amortization is calculated using
      straight-line method over the remaining lives.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

F-6

---

Medical Care Technologies Inc. 
  (A Development Stage Company) 
  Notes to the Consolidated Financial Statements 
  (unaudited)

| | Computer hardware              | 1 year 
| | ------------------------------ | -------
| | Computer equipment             | 2 years
| | Computer software and database | 1 year 

|   | Amortization and depreciation expense totaled $115,282
      and $nil for the three months ended March 31, 2010 and 2009,
      respectively.
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------
|   |                                                                                                                                              
|3. | Related Party Transactions                                                                                                                   
|   |                                                                                                                                              
|   | a)                                                                                                                                           
|   |                                                                                                                                              
|   | b)                                                                                                                                           
|   |                                                                                                                                              
|4. | Loans payable                                                                                                                                
|   |                                                                                                                                              
|   | a)                                                                                                                                           
|   |                                                                                                                                              
|   | b)                                                                                                                                           
|   |                                                                                                                                              
|   | c)                                                                                                                                           
|   |                                                                                                                                              
|   | d)                                                                                                                                           
|   |                                                                                                                                              
|   | e)                                                                                                                                           
|   |                                                                                                                                              
|5. | Common Stock                                                                                                                                 
|   |                                                                                                                                              
|   | a)                                                                                                                                           
|   |                                                                                                                                              
|   | b)                                                                                                                                           
|   |                                                                                                                                              
|   | c)                                                                                                                                           
|   |                                                                                                                                              
|   | d)                                                                                                                                           

F-7

---

- 3 -

|ITEM 2. | MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL
      CONDITION AND RESULTS OF OPERATIONS.
|------- | --------------------------------------------------------------------------------------------

Forward-Looking Statements

This
quarterly report includes a number of forward-looking statements that reflect
our current views with respect to future events and financial performance.
Forward-looking statements are often identified by words like: believe, expect,
estimate, anticipate, intend, project and similar expressions, or words which,
by their nature, refer to future events. You should not place undue certainty on
these forward-looking statements, which apply only as of the date of this
report. These forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from
historical results or our predictions.

We
are a start-up, development stage corporation and have not yet generated or
realized any revenues from our business activities.

These
financials have been prepared on a going concern basis. This means that there is
substantial doubt that we can continue as an on-going business for the next
twelve months unless we generate revenues. We currently do not have sufficient
capital to maintain operations for the next twelve months.

Liquidity and Capital Resources

The
accompanying financial statements have been prepared on a going concern basis,
which implies the Company will continue to realize its assets and discharge its
liabilities in the normal course of business. We have not generated any revenues
and we do not anticipate to generate any revenues until i) we begin implementing
our medical management software systems and devices in hospitals and clinics;
ii) sourcing, marketing and selling pharmaceutical and nutraceutical products to
healthcare providers and the general public and; iii) opening and serving
patients in our pharmacies and medical clinics. Accordingly, we must raise cash
from private investors, through equity financings or by developing strategic
alliances with other leading, world class players in the health industry. Our
only other source for cash at this time is monies raised in our recent private
placement. The cash we raised will allow us to stay in business for at least one
quarter. Our success or failure will be determined by creating alliances with
healthcare providers who need our medical technology, selling a large volume or
our products and opening a number of medical clinics and pharmacies throughout
China.

On
January 13, 2010, we completed a non-brokered private placement of 500,000 units
at a price of US$0.20 per unit for total proceeds of US$100,000. Each unit
purchased is comprised of one share of common stock and one Series A Warrant.
Each Series A Warrant is non-transferable and is convertible into one share of
common stock upon payment of $0.15 per Series A Warrant, exercisable for a
period of twenty four (24) months. The units were sold pursuant to the exemption
from registration contained in Regulation S of the Securities Act of 1933 in
that the transaction took place outside the United States of America and the
purchaser was a non-US person as defined in Regulation S. The securities that
comprise the units are restricted securities as that term is defined in Rule
144 of the Securities Act of 1933.

Results of Operations

As
of March 31, 2010, our total assets were $422,178 and our total liabilities were
$144,087. Total assets increased from December 31, 2009 by $421,703 mainly due
to an increase in prepaid expenses of $65,147 an increase in property and
equipment of $40,000 ($40,000 in 2010 and $-0- in 2009) and, an increase in
intangible assets of $315,846 ($315,846 in 2010 and $-0- in 2009). Total
liabilities increased by $16,706. This is mainly due to an increase in accrued
liabilities of $3,001 ($3,001 in 2010 and $-0- in 2009) and an increase in loans
payable of $66,987 ($80,987 in 2010 and $14,000 in 2009).

We
have no revenues in the periods ended March 31, 2010 and 2009. In the three
month periods ended March 31, 2010 and 2009, we incurred operating expenses of
$165,894 and $14,815, respectively. The losses are mainly due to an increase in
general and administrative of $20,797 ($35,612 in 2010 and $14,815 in 2009), an
increase in depreciation of $115,282 ($115,282 in 2010 and $-0- in 2009) and, an
increase in management fees of $15,000 ($15,000 in 2010 and $-0- in 2009). From
February 27, 2007 (inception date) to March 31, 2010 we

---

- 4 -

incurred a net loss of $344,537. Overall, operating expenses
increased due to an increase in professional fees related to legal and
accounting, filing fees and management fees as a result of the change in
business and the implementation of the Companys new business initiatives in
China.

Limited Capital

We
intend to use our limited cash to pay for our operations and legal, accounting
and professional services required to prepare and file our reports with the SEC.
Our remaining cash, however, will only be sufficient to sustain us for the
short-term. If we are unable to locate additional financing within the
short-term, we will be forced to suspend all public reporting with the SEC and
possibly liquidate.

General Overview

We
are a Chinese medical technology company engaged principally in the business of
i) providing healthcare services to children in China and ii) developing and
maintaining secure medical information systems used by healthcare institutions,
life science researchers, clinical laboratories, the pharmaceutical industry and
the general public.

Our
current operations consist of three business segments: Childrens Medical
Clinics, Medical Management Software Systems, and Pharmaceutical and
Nutraceutical Products.

Off-Balance Sheet Arrangements

We
have no off-balance sheet arrangements.

ITEM
3.           QUANTITATIVE AND
QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We
are a smaller reporting company as defined by Rule 12b-2 of the Securities
Exchange Act of 1934 and are not required to provide the information under this
item.

ITEM
4.           CONTROLS AND
PROCEDURES.

Under
the supervision and with the participation of our management, including the
Principal Executive Officer and Principal Financial Officer, we have evaluated
the effectiveness of our disclosure controls and procedures as required by
Exchange Act Rule 13a-15(b) as of the end of the period covered by this report.
Based on that evaluation, the Principal Executive Officer and Principal
Financial Officer have concluded that these disclosure controls and procedures
are not effective. In making this assessment, it used the criteria set forth by
the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in
Internal Control-Integrated Framework. Based on our assessment, we
believe that, as of March 31, 2010, our internal control over financial
reporting was not effective based on those criteria due to a lack of segregation
of duties, a lack of qualified accounting staff and an overreliance on
consultants in our accounting and financial reporting process. A material
weakness is a deficiency, or a combination of control deficiencies, in internal
control over financial reporting such that there is a reasonable possibility
that a material misstatement of our annual or interim financial statements will
not be prevented or detected on a timely basis. Notwithstanding, at this time
management has decided that considering the abilities of the persons involved
and the control procedures now in place, the risks associated with such lack of
segregation are low and the potential benefits of adding employees to further
segregate duties do not justify the substantial expenses associated with such
increases. Management will periodically reevaluate this situation.

There
were no changes in our internal control over financial reporting during the
quarter ended March 31, 2010 that have materially affected, or are reasonably
likely to materially affect, our internal control over financial reporting.

---

- 5 -

PART II. OTHER INFORMATION

**ITEM
1.**          **LEGAL
PROCEEDINGS.**

We
know of no material, existing or pending legal proceedings against our company,
nor are we involved as a plaintiff in any material proceeding or pending
litigation. There are no proceedings in which any of our directors, officers or
affiliates, or any registered or beneficial shareholder, is an adverse party or
has a material interest adverse to our interest.

**ITEM
1A.**        **RISK
FACTORS.**

We
are a smaller reporting company as defined by Rule 12b-2 of the Securities
Exchange Act of 1934 and are not required to provide the information under this
item.

**ITEM
2.**          **UNREGISTERED
SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.**

None.

**ITEM
3.**          **DEFAULTS
UPON SENIOR SECURITIES.**

None.

**ITEM
4.**          **[REMOVED AND RESERVED].**

**ITEM
5.**          **OTHER
EVENTS.**

On
January 9, 2010, the Company entered into an Asset Acquisition Agreement to
acquire various technologies associated with the development and maintenance of
secure information systems (the assets) held by Great Union Corporation
(Great Union), a Hong Kong corporation. In consideration, the Company agreed
to issue 57,300,000 shares of its common stock. The common stock issued pursuant
to the terms and conditions set forth in this Agreement will have such hold
periods as are required under applicable securities laws and as a result may not
be sold, transferred or otherwise disposed, except pursuant to an effective
registration statement under the Securities Act. The Company determined that the
fair value of the assets was $471,128.

On
February 1, 2010, the Company cancelled 57,300,000 shares of common stock from
the former President of the Company and issued these shares to Great Union with
a deemed fair value of $471,128.

On
January 12, 2010, Ning Wu was appointed to our board of directors and was
appointed our president, principal executive officer, principal financial
officer and principal accounting officer. Further, on the same date, Patricia
Traczykowski resigned from these positions.

On
January 12, 2010, Huong Nguyen was appointed to our board of directors and was
appointed as our chief operating officer. Further, on the same date Michael
Freeberg was appointed as our treasurer.

On
January 15, 2010, the Company accepted subscriptions for 500,000 units at $0.20
per unit for cash proceeds of $100,000. Each unit consisted of one share of
common stock of the Company and one common share purchase warrant exercisable at
$0.15 per share for a period of 36 months. The Company issued the shares on
February 1, 2010.

---

- 6 -

**ITEM
6.**          **EXHIBITS.**

The
following documents are included herein:

|Exhibit |                                                                                                                                                        
|------- | -------------------------------------------------------------------------------------------------------------------------------------------------------
|No.     | Document Description                                                                                                                                   
|        |                                                                                                                                                        
|31.1    | Certification
        of Principal Executive Officer and Principal Financial Officer pursuant
        to Section 302 of the Sarbanes-Oxley Act of 2002.
|        |                                                                                                                                                        
|32.1    | Certification
        of Chief Executive Officer and Chief Financial Officer pursuant to section
        906 of the Sarbanes-Oxley Act of 2002.        

---

- 7 -

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned, thereunto duly authorized.

|                    | **MEDICAL CARE TECHNOLOGIES INC.**
|------------------- | ----------------------------------
|                    |                                   
|                    |                                   
|Dated: May 24, 2010 | BY:                               
|                    |                                   
|                    |                                   
|                    |                                   
|                    |                                   
|                    |                                   

---

- 8 -

EXHIBIT INDEX

|Exhibit |                                                                                                                                                        
|------- | -------------------------------------------------------------------------------------------------------------------------------------------------------
|No.     | Document Description                                                                                                                                   
|        |                                                                                                                                                        
|31.1    | Certification
        of Principal Executive Officer and Principal Financial Officer pursuant
        to Section 302 of the Sarbanes-Oxley Act of 2002.
|        |                                                                                                                                                        
|32.1    | Certification
        of Chief Executive Officer and Chief Financial Officer pursuant to section
        906 of the Sarbanes-Oxley Act of 2002.        

---